Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)

Organon

Status and phase: Completed; Phase 4

Conditions: Cardiovascular Disorder

Treatments: Drug: Ezetimibe; Drug: simvastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00652717

2008_009

0653A-150

Details and patient eligibility

About

Collecting local data, safety and experience trial.

Enrollment: 280 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients; Post Acute Coronary Syndrome

Exclusion criteria

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

280 participants in 2 patient groups

1

Experimental group

Description:

arm 1 - Ezetimibe 10 mg daily that was added on Statin Therapy (prescribed clinically suitable dose by the physician).

Treatment:

Drug: simvastatin

Drug: Ezetimibe

2

Active Comparator group

Description:

arm 2- simvastatin (prescribed clinically suitable dose by the physician), for mean follow up of 42 days.

Treatment:

Drug: simvastatin